Continuous Venovenous Hemodiafiltration in the Treatment of Maple Syrup Urine Disease

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Blood Purification

• Publication date

  2016-03-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000443783PMID 26998605
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of intermittent hemodialysis in infants and young children with inborn errors of metabolism

  2013cited by this paper
• Branched-chain Organic Acidurias /Acidaemias

  2012cited by this paper
• Controversies in paediatric continuous renal replacement therapy

  2009cited by this paper
• Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease

  2008cited by this paper
• Duration of extracorporeal therapy in acute maple syrup urine disease: a kinetic model

  2006cited by this paper
• Kinetic Modeling of Plasma Leucine Levels during Continuous Venovenous Extracorporeal Removal Therapy in Neonates with Maple Syrup Urine Disease

  2005cited by this paper
• Renal replacement therapy for acute renal failure in children: European Guidelines

  2003cited by this paper
• Utility of hemodialysis in maple syrup urine disease

  2002cited by this paper
• Diagnosis and treatment of maple syrup disease: a study of 36 patients.

  2002cited by this paper
• Continuous renal replacement therapy for non-renal indications: experience in children.

  2002cited by this paper
• Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease

  2001cited by this paper
• Outcome in children receiving continuous venovenous hemofiltration.

  2001cited by this paper
• Management of acute metabolic decompensation in maple syrup urine disease: A multi‐center study

  1999cited by this paper
• Renal clearance of branched-chain L-amino and 2-oxo acids in maple syrup urine disease

  1999cited by this paper
• Dialysis in neonates with inborn errors of metabolism.

  1999cited by this paper
• Metabolism of branched-chain amino acids in maple syrup urine disease

  1997cited by this paper
• Continuous venovenous haemodiafiltration in the acute phase of neonatal maple syrup urine disease

  1997cited by this paper
• A Comparison of Solute Clearance During Continuous Hemofiltration, Hemodiafiltration, and Hemodialysis Using a Polysulfone Hemofilter

  1995cited by this paper
• Continuous venovenous haemofiltration in the acute treatment of inborn errors of metabolism

  1994cited by this paper
• Acute hemodialysis of infants weighing less than five kilograms.

  1994cited by this paper
• Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity.

  1994cited by this paper
• Removal of Branched-Chain Amino Acids by Peritoneal Dialysis, Continuous Arteriovenous Hemofiltration, and Continuous Arteriovenous Hemodialysis in Rabbits: Implications for Maple Syrup Urine Disease Treatment

  1994cited by this paper
• Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism.

  1990cited by this paper
• The Relationship between the Branched Chain Amino Acids and Their α-Ketoacids in Maple Syrup Urine Disease

  1984cited by this paper
• Peritoneal dialysis in maple-syrup-urine disease: Studies on branched-chain amino and keto acids

  1980cited by this paper
• Assessment of coma and impaired consciousness. A practical scale.

  1974cited by this paper

• Inborn errors of metabolism in neonates and pediatrics on varying dialysis modalities: a systematic review and meta-analysis

  2024cites this paper
• Metabolic crisis in maple syrup urine disease: an unusual complication of a rare disease: a case report

  2023cites this paper
• A novel mutation in the DBT gene causes in an Azerbaijanian child classic maple syrup urine disease

  2022cites this paper
• Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease

  2022cites this paper
• Continuous veno‐venous hemodiafiltration in neonates with maple syrup urine disease

  2022cites this paper
• Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders

  2021cites this paper
• [Peritoneal dialysis in a neonate with maple syrup urine disease. A case report].

  2020cites this paper
• Impact of sodium phenylbutyrate treatment in acute management of maple syrup urine disease attacks: a single-center experience

  2020cites this paper
• Leucinosis, or maple syrup urine disease (lecture and a clinical case)

  2020cites this paper
• Continuous Renal Replacement Therapy with High Flow Rate Can Effectively, Safely, and Quickly Reduce Plasma Ammonia and Leucine Levels in Children

  2019cites this paper
• Treatment of maple syrup urine disease with high flow hemodialysis in a neonate.

  2019cites this paper
• Short-term results of continuous venovenous haemodiafiltration versus peritoneal dialysis in 40 neonates with inborn errors of metabolism

  2019cites this paper
• Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox.

  2018cites this paper